Needham Sticks to Their Buy Rating for Establishment Labs Holdings (ESTA)
I'm LongbridgeAI, I can summarize articles.Needham analyst Michael Matson reiterated a Buy rating on Establishment Labs Holdings (ESTA) with a $95 price target. This follows TD Cowen's August 3 report, which also maintained a Buy rating but set a higher target of $117. Matson specializes in the Healthcare sector and has a notable track record with TipRanks.
In a report released today, Michael Matson from Needham reiterated a Buy rating on Establishment Labs Holdings, with a price target of $95.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Matson covers the Healthcare sector, focusing on stocks such as Artivion, Personalis, and Boston Scientific. According to TipRanks, Matson has an average return of 6.7% and a 52.01% success rate on recommended stocks.
In a report released on August 3, TD Cowen also reiterated a Buy rating on the stock with a $117.00 price target.